AllianceBernstein’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-144,400
| Closed | -$592K | – | 3470 |
|
|
2022
Q1 | $592K | Buy |
144,400
+500
| +0.3% | +$1.81K | ﹤0.01% | 2607 |
|
|
2021
Q4 | $514K | Sell |
143,900
-150,979
| -51% | -$528K | ﹤0.01% | 2730 |
|
|
2021
Q3 | $1.07M | Buy |
294,879
+150,979
| +105% | +$610K | ﹤0.01% | 2470 |
|
|
2021
Q2 | $627K | Buy |
143,900
+11,600
| +9% | +$47.3K | ﹤0.01% | 2724 |
|
|
2021
Q1 | $544K | Sell |
132,300
-18,100
| -12% | -$78.4K | ﹤0.01% | 2628 |
|
|
2020
Q4 | $600K | Buy |
150,400
+8,500
| +6% | +$27.5K | ﹤0.01% | 2507 |
|
|
2020
Q3 | $383K | Sell |
141,900
-10,000
| -7% | -$27.7K | ﹤0.01% | 2676 |
|
|
2020
Q2 | $418K | Sell |
151,900
-1,100
| -0.7% | -$3.07K | ﹤0.01% | 2725 |
|
|
2020
Q1 | $361K | Hold |
153,000
| – | – | ﹤0.01% | 2521 |
|
|
2019
Q4 | $719K | Hold |
153,000
| – | – | ﹤0.01% | 2407 |
|
|
2019
Q3 | $512K | Hold |
153,000
| – | – | ﹤0.01% | 2538 |
|
|
2019
Q2 | $503K | Buy |
153,000
+11,400
| +8% | +$33K | ﹤0.01% | 2597 |
|
|
2019
Q1 | $429K | Buy |
141,600
+5,300
| +4% | +$17.2K | ﹤0.01% | 2583 |
|
|
2018
Q4 | $371K | Buy |
136,300
+38,300
| +39% | +$126K | ﹤0.01% | 2613 |
|
|
2018
Q3 | $329K | Buy |
98,000
+12,700
| +15% | +$39.2K | ﹤0.01% | 2802 |
|
|
2018
Q2 | $220K | Buy |
85,300
+23,000
| +37% | +$57.2K | ﹤0.01% | 2938 |
|
|
2018
Q1 | $137K | Buy |
62,300
+12,700
| +26% | +$28.6K | ﹤0.01% | 2934 |
|
|
2017
Q4 | $99K | Buy |
49,600
+12,700
| +34% | +$27.6K | ﹤0.01% | 2966 |
|
|
2017
Q3 | $120K | Hold |
36,900
| – | – | ﹤0.01% | 3026 |
|
|
2017
Q2 | $119K | Buy |
+36,900
| New | +$105K | ﹤0.01% | 3082 |
|
|
2016
Q2 | – | Sell |
-186,800
| Closed | -$163K | – | 3011 |
|
|
2016
Q1 | $163K | Sell |
186,800
-10,000
| -5% | -$9.68K | ﹤0.01% | 2756 |
|
|
2015
Q4 | $238K | Sell |
196,800
-500
| -0.3% | -$696 | ﹤0.01% | 2693 |
|
|
2015
Q3 | $335K | Hold |
197,300
| – | – | ﹤0.01% | 2630 |
|
|
2015
Q2 | $410K | Hold |
197,300
| – | – | ﹤0.01% | 2657 |
|
|
2015
Q1 | $535K | Hold |
197,300
| – | – | ﹤0.01% | 2463 |
|
|
2014
Q4 | $507K | Sell |
197,300
-10,600
| -5% | -$23.8K | ﹤0.01% | 2508 |
|
|
2014
Q3 | $380K | Sell |
207,900
-13,200
| -6% | -$28.8K | ﹤0.01% | 2585 |
|
|
2014
Q2 | $590K | Sell |
221,100
-289
| -0.1% | -$870 | ﹤0.01% | 2471 |
|
|
2014
Q1 | $775K | Sell |
221,389
-11,834
| -5% | -$52.5K | ﹤0.01% | 2283 |
|
|
2013
Q4 | $1.04M | Sell |
233,223
-14,000
| -6% | -$57K | ﹤0.01% | 2129 |
|
|
2013
Q3 | $1M | Buy |
247,223
+14,725
| +6% | +$64.3K | ﹤0.01% | 2126 |
|
|
2013
Q2 | $967K | Buy |
+232,498
| New | +$898K | ﹤0.01% | 2098 |
|
Other funds holding ATRS
AllianceBernstein's ATRS Position: Q2 2022 in Review
AllianceBernstein sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 144,400 shares — an estimated $592K sold.
AllianceBernstein first reported a position in ATRS in Q2 2013 and held it in 32 quarters. The position peaked at $1.07M in Q3 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- AllianceBernstein reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- AllianceBernstein sold 144,400 Antares Pharma, Inc. shares in Q2 2022, an estimated $592K.
- AllianceBernstein first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 32 quarters.
- AllianceBernstein's Antares Pharma, Inc. position peaked at $1.07M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.